General Announcement::Approval of Drug Clinical Trials for Uterine Fibroids Indication of Innovative Drug CMS-D002

Issuer & Securities

Issuer/ Manager
CHINA MEDICAL SYSTEM HOLDINGS LIMITED
Securities
CHINA MEDICAL SYSTEM HLDGS LTD - KYG211081248 - 8A8
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
26-Sep-2025 19:40:58
Status
New
Announcement Sub Title
Approval of Drug Clinical Trials for Uterine Fibroids Indication of Innovative Drug CMS-D002
Announcement Reference
SG250926OTHR4535
Submitted By (Co./ Ind. Name)
Wu Sanyan
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Please refer to the attachment.

Attachments

CMS-Approval of Drug Clinical Trials for Uterine Fibroids Indication of Innovative Drug CMS-D002.pdf
Total size =164K